{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:29:20Z","timestamp":1762324160373},"reference-count":38,"publisher":"Japanese Society of Toxicology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2131\/jts.42.589","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T18:19:38Z","timestamp":1505240378000},"page":"589-596","source":"Crossref","is-referenced-by-count":19,"title":["Assessment of amiodarone-induced phospholipidosis in chimeric mice with a humanized liver"],"prefix":"10.2131","volume":"42","author":[{"given":"Seigo","family":"Sanoh","sequence":"first","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Yamachika","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Tamura","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaichiro","family":"Kotake","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumi","family":"Yoshizane","sequence":"additional","affiliation":[{"name":"R&D Dept., PhoenixBio, Co., Ltd."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Ishida","sequence":"additional","affiliation":[{"name":"R&D Dept., PhoenixBio, Co., Ltd."},{"name":"Liver Research Project Center, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chise","family":"Tateno","sequence":"additional","affiliation":[{"name":"R&D Dept., PhoenixBio, Co., Ltd."},{"name":"Liver Research Project Center, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Ohta","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","unstructured":"Baronas, E.T., Lee, J.W., Alden, C. and Hsieh, F.Y. (2007): Biomarkers to monitor drug-induced phospholipidosis. Toxicol. Appl. Pharmacol., <b>218<\/b>, 72-78."},{"key":"2","unstructured":"Bligh, E.G. and Dyer, W.J. (1959): A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., <b>37<\/b>, 911-917."},{"key":"3","unstructured":"Buck, A., Halbritter, S., Sp\u00e4th, C., Feuchtinger, A., Aichler, M., Zitzelsberger, H., Janssen, K.-P. and Walch, A. (2015): Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. Anal. Bioanal. Chem., <b>407<\/b>, 2107-2116."},{"key":"4","unstructured":"Buratta, S., Urbanelli, L., Ferrara, G., Sagini, K., Goracci, L. and Emiliani, C. (2015): A role for the autophagy regulator Transcription Factor EB in amiodarone-induced phospholipidosis. Biochem. Pharmacol., <b>95<\/b>, 201-209."},{"key":"5","unstructured":"Delaney, J., Neville, W.A., Swain, A., Miles, A., Leonard, M.S. and Waterfield, C.J. (2004): Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model. Biomarkers, <b>9<\/b>, 271-290."},{"key":"6","unstructured":"Goto, T., Terada, N., Inoue, T., Nakayama, K., Okada, Y., Yoshikawa, T., Miyazaki, Y., Uegaki, M., Sumiyoshi, S., Kobayashi, T., Kamba, T., Yoshimura, K. and Ogawa, O. (2014): The expression profile of phosphatidylinositol in high spatial resolution imaging mass spectrometry as a potential biomarker for prostate cancer. PLoS One,<b> 9<\/b>, e90242."},{"key":"7","unstructured":"Groseclose, M.R., Laffan, S.B., Frazier, K.S., Hughes-Earle, A. and Castellino, S. (2015): Imaging MS in toxicology: An investigation of juvenile rat nephrotoxicity associated with dabrafenib administration. J. Am. Soc. Mass Spectrom., <b>26<\/b>, 887-898."},{"key":"8","unstructured":"Halliwell, W.H. (1997): Cationic amphiphilic drug-induced phospholipidosis. Toxicol. Pathol., <b>25<\/b>, 53-60."},{"key":"9","unstructured":"Hamaguchi, R., Tanimoto, T. and Kuroda, Y. (2014): Putative biomarker for phospholipid accumulation in cultured cells treated with phospholipidosis-inducing drugs: alteration of the phosphatidylinositol composition detected using high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., <b>967<\/b>, 110-117."},{"key":"10","unstructured":"Kakuni, M., Morita, M., Matsuo, K., Katoh, Y., Nakajima, M., Tateno, C. and Yokoi, T. (2012): Chimeric mice with a humanized liver as an animal model of troglitazone-induced liver injury. Toxicol. Lett., <b>214<\/b>, 9-18."},{"key":"11","unstructured":"Kannan, R., Sarma, J.S.M., Guha, M. and Venkataraman, K. (1991): Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam. Appl. Toxicol., <b>16<\/b>, 103-109."},{"key":"12","unstructured":"Kasahara, T., Tomita, K., Murano, H., Harada, T., Tsubakimoto, K., Ogihara, T., Ohnishi, S. and Kakinuma, C. (2006): Establishment of an <i>in vitro<\/i> high-throughput screening assay for detecting phospholipidosis-inducing potential. Toxicol. Sci., <b>90<\/b>, 133-141."},{"key":"13","unstructured":"Kawashima, M., Iwamoto, N., Kawaguchi-Sakita, N., Sugimoto, M., Ueno, T., Mikami, Y., Terasawa, K., Sato, T.A., Tanaka, K., Shimizu, K. and Toi, M. (2013): High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci., <b>104<\/b>, 1372-1379."},{"key":"14","unstructured":"Mesens, N., Desmidt, M., Verheyen, G.R., Starckx, S., Damsch, S., De Vries, R., Verhemeldonck, M., Van Gompel, J., Lampo, A. and Lammens, L. (2012): Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP. Toxicol. Pathol., <b>40<\/b>, 491-503."},{"key":"15","unstructured":"Miyamura, N., Nakamura, T., Goto-Inoue, N., Zaima, N., Hayasaka, T., Yamasaki, T., Terai, S., Sakaida, I., Setou, M. and Nishina, H. (2011): Imaging mass spectrometry reveals characteristic changes in triglyceride and phospholipid species in regenerating mouse liver. Biochem. Biophys. Res. Commun., <b>408<\/b>, 120-125."},{"key":"16","unstructured":"Morelli, J.K., Buehrle, M., Pognan, F., Barone, L.R., Fieles, W. and Ciaccio, P.J. (2006): Validation of an<i> in vitro<\/i> screen for phospholipidosis using a high-content biology platform. Cell. Biol. Toxicol., <b>22<\/b>, 15-27."},{"key":"17","unstructured":"Nonoyama, T. and Fukuda, R. (2008): Drug-induced phospholipidosis: pathological aspects and its prediction. J. Toxicol. Pathol., <b>21<\/b>, 9-24."},{"key":"18","unstructured":"Ohtsuki, S., Kawakami, H., Inoue, T., Nakamura, K., Katsukura, Y., Obuchi, W., Uchida, Y., Kamiie, J., Toru, H. and Tetasaki, T. (2014): Validation of uPA\/SCID mouse with humanized liver as a human liver model : protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS\/MS. Drug Metab. Dispos., <b>42<\/b>, 1039-1043."},{"key":"19","unstructured":"Rodrigues, M., Alves, G., Abrantes, J. and Falc\u00e3o, A. (2013): Herb-drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice. Food. Chem. Toxicol., <b>52<\/b>, 121-128."},{"key":"20","unstructured":"Sanoh, S. and Ohta, S. (2014): Chimeric mice transplanted with human hepatocytes as a model for prediction of human drug metabolism and pharmacokinetics. Biopharm. Drug Dispos., <b>35<\/b>, 71-86."},{"key":"21","unstructured":"Sanoh, S., Naritomi, Y., Fujimoto, M., Sato, K., Kawamura, A., Horiguchi, A., Sugihara, K., Kotake, Y., Ohshita, H., Tateno, C., Horie, T., Kitamura, S. and Ohta, S. (2015): Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica, <b>45<\/b>, 605-614."},{"key":"22","unstructured":"Sawada, H., Takami, K. and Asahi, S. (2005): A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel<i> in vitro<\/i> screening system. Toxicol. Sci.,<b> 83<\/b>, 282-292."},{"key":"23","unstructured":"Seiler, K.U. and Wassermann, O. (1975): Drug-induced phospholipidosis. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol., <b>288<\/b>, 261-268."},{"key":"24","unstructured":"Shimma, S., Sugiura, Y., Hayasaka, T., Hoshikawa, Y., Noda, T. and Setou, M. (2007): MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., <b>855<\/b>, 98-103."},{"key":"25","unstructured":"Sirajudeen, K.N., Gurumoorthy, P., Devaraj, H. and Devaraj, S.N. (2002): Amiodarone-induced phospholipidosis: An<i> in vivo<\/i> [<sup>14<\/sup>C]-acetate uptake study in rat. Drug Chem. Toxicol., <b>25<\/b>, 247-254."},{"key":"26","unstructured":"Snel, M.F. and Fuller, M. (2010): High-spatial resolution matrix-assisted laser desorption ionization imaging analysis of glucosylceramide in spleen sections from a mouse model of Gaucher disease. Anal. Chem., <b>82<\/b>, 3664-3670."},{"key":"27","unstructured":"Song, M., Kim, Y.J. and Ryu, J.C. (2011): Phospholipidosis induced by PPAR\u03b3 signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone. Toxicol. Sci., <b>120<\/b>, 98-108."},{"key":"28","unstructured":"Sugiura, Y. and Setou, M. (2010): Imaging mass spectrometry for visualization of drug and endogenous metabolite distribution: Toward in situ pharmacometabolomes. J. Neuroimmune Pharmacol., <b>5<\/b>, 31-43."},{"key":"29","unstructured":"Sun, N., Fernandez, I.E., Wei, M., Wu, Y., Aichler, M., Eickelberg, O. and Walch, A. (2016): Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging. Histochem. Cell Biol., <b>145<\/b>, 201-211."},{"key":"30","unstructured":"Takagi, M., Sanoh, S., Santoh, M., Ejiri, Y., Kotake, Y. and Ohta, S.(2016): Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids. J. Toxicol. Sci., <b>41<\/b>, 155-164."},{"key":"31","unstructured":"Takai, N. and Tanaka, Y. (2015): Imaging of drug and metabolite distribution by MS: case studies. Bioanalysis, <b>7<\/b>, 2639-2648."},{"key":"32","unstructured":"Takai, S., Oda, S., Tsuneyama, K., Fukami, T., Nakajima, M. and Yokoi, T. (2016): Establishment of a mouse model for amiodarone-induced liver injury and analyses of its hepatotoxic mechanism. J. Appl. Toxicol.,<b> 36<\/b>, 35-47."},{"key":"33","unstructured":"Tateno, C., Yoshizane, Y., Saito, N., Kataoka, M., Utoh, R., Yamasaki, C., Tachibana, A., Soeno, Y., Asahina, K., Hino, H., Asahara, T., Yokoi, T., Furukawa, T. and Yoshizato, K. (2004): Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol., <b>165<\/b>, 901-912."},{"key":"34","unstructured":"Tateno, C., Kawase, Y., Tobita, Y., Hamamura, S., Ohshita, H., Yokomichi, H., Sanada, H., Kakuni, M., Shiota, A., Kojima, Y., Ishida, Y., Shitara, H., Wada, N.A., Tateishi, H., Sudoh, M., Nagatsuka, S.I., Jishage, K.I. and Kohara, M. (2015a): Generation of novel Chimeric mice with humanized livers by using hemizygous cDNA-uPA\/SCID mice. PLoS One, <b>10<\/b>, e0142145."},{"key":"35","unstructured":"Tateno, C., Yamamoto, T., Utoh, R., Yamasaki, C., Ishida, Y., Myoken, Y., Oofusa, K., Okada, M., Tsutsui, N. and Yoshizato, K. (2015b): Chimeric Mice with Hepatocyte-humanized Liver as an Appropriate Model to Study Human Peroxisome Proliferator-activated Receptor-\u03b1. Toxicol. Pathol., <b>43<\/b>, 233-248."},{"key":"36","unstructured":"Vitins, A.P., Kienhuis, A.S., Speksnijder, E.N., Roodbergen, M., Luijten, M. and van der Ven, L.T. (2014): Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse<i> in vivo<\/i> act as a template for other hepatotoxicity models. Arch. Toxicol., <b>88<\/b>, 1573-1588."},{"key":"37","unstructured":"Zaima, N., Yoshioka, S., Sato, Y., Shinano, S., Ikeda, Y. and Moriyama, T. (2014): Enhanced specificity for phosphatidylcholine analysis by positive ion mode matrix-assisted laser desorption\/ionization imaging mass spectrometry. Rapid. Commun. Mass Spectrom., <b>28<\/b>, 1453-1458."},{"key":"38","unstructured":"Zhou, L., Geraci, G., Hess, S., Yang, L., Wang, J. and Argikar, U. (2011): Predicting phospholipidosis: a fluorescence noncell based <i>in vitro<\/i> assay for the determination of drug-phospholipid complex formation in early drug discovery. Anal. Chem., <b>83<\/b>, 6980-6987."}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/5\/42_589\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T23:42:10Z","timestamp":1505518930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/42\/5\/42_589\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.42.589","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}